Novavax Aktie
5,95
EUR
+0,29
EUR
+5,07
%
7,02
USD
-0,01
USD
-0,14
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 5 | 3 | 0 | 136,29 GBP | +31,81% |
| Bayer | 2 | 7 | 0 | 26,43 EUR | -2,69% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +21,20% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 49,38 EUR | +4,53% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,29 EUR | +17,50% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +106,91% |
| Novartis AG | 3 | 5 | 1 | 100,00 CHF | +2,34% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +13,86% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 270,86 CHF | +5,11% |
| Sanofi S.A. | 6 | 3 | 0 | 112,86 EUR | +34,89% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |